After Merrill Lynch and Morgan Stanley gave Colgate-Palmolive (NYSE: CL) a Buy rating last month, the company received another Buy, this time from RBC Capital. Analyst Nik Modi maintained a Buy rating on Colgate-Palmolive today and set a price target of $91.00. The company’s shares closed last Monday at $60.46, close to its 52-week low of $60.04.
According to TipRanks.com, Modi is a 3-star analyst with an average return of 0.7% and a 56.3% success rate. Modi covers the Consumer Goods sector, focusing on stocks such as The Estée Lauder Companies, Mondelez International, and Edgewell Personal Care.
Colgate-Palmolive has an analyst consensus of Moderate Buy, with a price target consensus of $75.90, representing a 22.2% upside. In a report issued on March 20, Merrill Lynch also upgraded the stock to Buy.
See today’s analyst top recommended stocks >>
Colgate-Palmolive’s market cap is currently $53.08B and has a P/E ratio of 22.58. The company has a Price to Book ratio of 453.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Colgate-Palmolive Co. is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments.
